XBiotech Inc.

XBiotech Inc. is not a good growth stock. XBiotech Inc. is a mediocre stock to choose.
Log in to see more information.
XBiotech, Inc. is a biopharmaceutical company, which engages in development and commercialization of...

News

Is XBiotech (NASDAQ:XBIT) Weighed On By Its Debt Load?
Is XBiotech (NASDAQ:XBIT) Weighed On By Its Debt Load?

Simply Wall St David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...\n more…

XBIT Stock Earnings: XBiotech Reported Results for Q2 2024
XBIT Stock Earnings: XBiotech Reported Results for Q2 2024

InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nXBiotech just reported results for the second quarter of 2024.\nThe post XBIT Stock Earnings: XBiotech Reported Results for Q2 2024...\n more…

XBiotech Inc. (NASDAQ:XBIT) Sees Significant Increase in Short Interest
XBiotech Inc. (NASDAQ:XBIT) Sees Significant Increase in Short Interest

Zolmax XBiotech Inc. (NASDAQ:XBIT - Get Free Report) saw a large growth in short interest during the month of July. As of July 15th, there was short interest totalling 946,100 shares, a growth of 68.0...\n more…

XBiotech Inc. (NASDAQ:XBIT) Short Interest Down 14.3% in June
XBiotech Inc. (NASDAQ:XBIT) Short Interest Down 14.3% in June

Ticker Report XBiotech Inc. (NASDAQ:XBIT - Get Free Report) was the recipient of a large drop in short interest in June. As of June 30th, there was short interest totalling 563,100 shares, a drop of 14.3% from the...\n more…

Short Interest in XBiotech Inc. (NASDAQ:XBIT) Drops By 14.3%
Short Interest in XBiotech Inc. (NASDAQ:XBIT) Drops By 14.3%

Zolmax XBiotech Inc. (NASDAQ:XBIT - Get Free Report) was the recipient of a significant drop in short interest during the month of June. As of June 30th, there was short interest totalling 563,100 shares...\n more…

XBiotech Inc. (NASDAQ:XBIT) surges 26%; individual investors who own 51% shares profited along with insiders
XBiotech Inc. (NASDAQ:XBIT) surges 26%; individual investors who own 51% shares profited along with insiders

Simply Wall St Key Insights The considerable ownership by individual investors in XBiotech indicates that they collectively have a...\n more…